Pages that link to "Q49970"
Jump to navigation
Jump to search
The following pages link to hyperuricemia (Q49970):
Displaying 50 items.
- arteriosclerosis (Q184559) (← links)
- allopurinol (Q412486) (← links)
- febuxostat (Q417296) (← links)
- mannitol hexanitrate (Q1890796) (← links)
- rasburicase (Q3088229) (← links)
- Kelley–Seegmiller syndrome (Q10376433) (← links)
- Hypoxanthine-guanine phosophoribosyltransferase (HPRT) deficiency: Lesch-Nyhan syndrome (Q21202956) (← links)
- A concise history of gout and hyperuricemia and their treatment (Q24633751) (← links)
- Rasburicase represents a new tool for hyperuricemia in tumor lysis syndrome and in gout (Q24673444) (← links)
- Mechanistic insights into xanthine oxidoreductase from development studies of candidate drugs to treat hyperuricemia and gout (Q27023909) (← links)
- Fasturtec (Q29005859) (← links)
- Zurampic (Q29006758) (← links)
- Fructose Intake, Serum Uric Acid, and Cardiometabolic Disorders: A Critical Review. (Q30234756) (← links)
- Sex-Specific Relationship Between Serum Uric Acid and Risk of Stroke: A Dose-Response Meta-Analysis of Prospective Studies (Q30235039) (← links)
- A review of uric acid, crystal deposition disease, and gout (Q30619265) (← links)
- Management of hyperuricemia in gout: focus on febuxostat. (Q33635542) (← links)
- Uric acid as one of the important factors in multifactorial disorders – facts and controversies (Q33773142) (← links)
- Impact of comorbidities on gout and hyperuricaemia: an update on prevalence and treatment options (Q33864537) (← links)
- Sugar, uric acid, and the etiology of diabetes and obesity. (Q34038315) (← links)
- Is hyperuricemia an independent risk factor for new-onset chronic kidney disease?: A systematic review and meta-analysis based on observational cohort studies (Q34042891) (← links)
- The effects of fructose intake on serum uric acid vary among controlled dietary trials. (Q34211386) (← links)
- Switching from allopurinol to febuxostat for the treatment of hyperuricemia and renal function in patients with chronic kidney disease (Q34317722) (← links)
- Effects of hyperuricemia on renal function of renal transplant recipients: a systematic review and meta-analysis of cohort studies (Q34321410) (← links)
- Hyperuricemia and risk of incident hypertension: a systematic review and meta-analysis of observational studies (Q34601785) (← links)
- The pathophysiology of hyperuricaemia and its possible relationship to cardiovascular disease, morbidity and mortality (Q34877729) (← links)
- A case series of allopurinol-induced toxic epidermal necrolysis (Q34941868) (← links)
- New and improved strategies for the treatment of gout (Q35026692) (← links)
- An update on the genetic architecture of hyperuricemia and gout (Q35359040) (← links)
- Recent developments in our understanding of the renal basis of hyperuricemia and the development of novel antihyperuricemic therapeutics (Q35578918) (← links)
- Urate lowering therapy to improve renal outcomes in patients with chronic kidney disease: systematic review and meta-analysis (Q35605560) (← links)
- Coronary artery bypass grafting in a patient with gout arthritis (Q35733468) (← links)
- Update on the Phenotypic Spectrum of Lesch-Nyhan Disease and its Attenuated Variants (Q36128728) (← links)
- Fructose intake and risk of gout and hyperuricemia: a systematic review and meta-analysis of prospective cohort studies (Q36152073) (← links)
- Hyperuricemia and coronary heart disease mortality: a meta-analysis of prospective cohort studies (Q36177428) (← links)
- Hyperuricemia increases the risk of acute kidney injury: a systematic review and meta-analysis. (Q36251821) (← links)
- Is tea consumption associated with the serum uric acid level, hyperuricemia or the risk of gout? A systematic review and meta-analysis (Q36293221) (← links)
- Prevalence of Hyperuricemia and Gout in Mainland China from 2000 to 2014: A Systematic Review and Meta-Analysis (Q36310374) (← links)
- Highly Prevalent Hyperuricaemia Is Associated With Adverse Clinical Outcomes Among Ghanaian Stroke Patients: an Observational Prospective Study (Q36365434) (← links)
- Management of Chronic Kidney Disease: The Relationship Between Serum Uric Acid and Development of Nephropathy (Q36373688) (← links)
- Hyperuricemia and the risk for coronary heart disease morbidity and mortality a systematic review and dose-response meta-analysis (Q36506786) (← links)
- Chronic hyperuricemia, uric acid deposit and cardiovascular risk (Q36712438) (← links)
- Association of Serum Uric Acid Levels in Psoriasis: A Systematic Review and Meta-Analysis (Q36993602) (← links)
- Is coffee consumption associated with a lower risk of hyperuricaemia or gout? A systematic review and meta-analysis (Q37100832) (← links)
- Hyperuricemia-Related Diseases and Xanthine Oxidoreductase (XOR) Inhibitors: An Overview (Q37127097) (← links)
- Comparative efficacy and safety of urate-lowering therapy for the treatment of hyperuricemia: a systematic review and network meta-analysis (Q37240086) (← links)
- Gout. Novel therapies for treatment of gout and hyperuricemia (Q37350841) (← links)
- Gout. Hyperuricemia and cardiovascular disease: how strong is the evidence for a causal link? (Q37350881) (← links)
- An evidence-based review on urate-lowering treatments: implications for optimal treatment of chronic hyperuricemia (Q37641297) (← links)
- New advances in the treatment of gout: review of pegloticase (Q37815379) (← links)
- Hyperuricaemia, Xanthine Oxidoreductase and Ribosome-Inactivating Proteins from Plants: The Contributions of Fiorenzo Stirpe to Frontline Research. (Q39109285) (← links)